- Pharmacy Profile Name: Tailor Made Compounding (TMC Acquisition LLC)
- Website: tailormadecompounding.com
- Location: Nicholasville, Kentucky
- Pharmacy Type: 503A compounding pharmacy
- Accreditations: NABP Compounding Pharmacy Accreditation; LegitScript certified
- GLP-1 Products: Weight management / GLP-1 compounding confirmed as an active specialty area; specific semaglutide and tirzepatide formulation details not publicly listed (prescriber-facing platform)
- Licensed States: 46 states; limited shipping to California; no shipping to Alabama, Arkansas, North Carolina, or Minnesota
- Telehealth Partners: Works through prescriber network (provider portal); no named telehealth brand partnerships published publicly
- Payment: Cash-pay only; no insurance, FSA, or HSA accepted
About the Pharmacy
Tailor Made Compounding is a 503A compounding pharmacy located in Nicholasville, Kentucky. Licensed in 46 states and holding LegitScript certification and NABP accreditation, it prides itself on offering healthcare practitioners and patients high-quality, custom-compounded formulations and outstanding customer service. The pharmacy operates out of a 20,000 square foot compounding facility designed to exceed current United States Pharmacopeia guidelines.
As experts in compounded medications, Tailor Made Compounding provides custom wellness solutions to satisfy the unique needs of all types of patients, with a focus spanning HRT, peptide therapies, anti-aging, weight management, and other individualized treatments. Ownership transferred in March 2021, with the current leadership publicly prioritizing compliance, quality infrastructure, and prescriber education.
GLP-1 Compounding
Weight management is listed among Tailor Made Compounding’s core specialty areas alongside men’s health, women’s health, anti-aging, IV therapy, and supplements. Specific GLP-1 formulations are managed through the pharmacy’s prescriber portal rather than a public-facing consumer product catalog, consistent with its business-to-prescriber model.
Tailor Made Compounding sources all raw materials from FDA-registered manufacturers and distributors, performs third-party sterility testing on all compounded sterile batches, captures images of every order throughout each stage of fulfillment, and makes sterility reports available upon request for all sterile orders. Real-time monitoring is maintained in all ISO-classified sterile compounding rooms.
As a 503A compounding pharmacy, all prescriptions must be patient-specific. The pharmacy is cash-based and does not accept insurance, FSA, or HSA.
Type of Pharmacy
Tailor Made Compounding is licensed in 46 states for both sterile and nonsterile compounding and is subject to regular inspections by state boards of pharmacy, including the Kentucky State Board of Pharmacy and the California State Board of Pharmacy, as well as third-party inspections by NABP’s Verified Pharmacy Program. Tailor Made Compounding is in good standing in all 46 states in which it is licensed.
States Licensed In
Tailor Made Compounding ships to 46 states, plus Puerto Rico and Washington DC. California is listed as limited shipping. States where the pharmacy does not currently ship include Alabama, Arkansas, North Carolina, and Minnesota.
Telehealth Providers They Work With
Tailor Made Compounding operates on a prescriber-to-pharmacy model with a dedicated provider portal. No named consumer-facing telehealth brand partnerships were found in public-facing materials as of March 2026. Clinicians and practices enroll through the pharmacy’s prescriber network and submit patient-specific prescriptions directly. This is consistent with its B2B orientation toward integrative medicine practices, functional medicine clinicians, and anti-aging/wellness providers.
Pricing from Reviews
No GLP-1-specific pricing is published publicly. As a prescriber-facing, cash-based compounding pharmacy, pricing is quoted through the prescriber portal and varies by formulation and patient-specific order.
Overall Reviews
Patient-facing public reviews are limited, reflecting Tailor Made Compounding’s prescriber-network model rather than a direct-to-consumer brand. Employee reviews on Glassdoor and Indeed post-2021 are broadly positive, describing a strong culture, growth trajectory, and improved management under new ownership.
The pharmacy carries a notable regulatory history that prospective prescribers should be aware of. Under prior ownership, the pharmacy received an FDA Warning Letter in April 2020 for marketing thymosin alpha-1 with false claims that it was FDA-approved, including misleading statements made to clinicians during the COVID-19 pandemic. Ownership changed in March 2021. Under current ownership, a February 2022 FDA inspection resulted in a Form 483 with observations including sterile compounding technique issues in ISO-classified cleanrooms and facility maintenance concerns; several implicated batches were quarantined by the pharmacy itself. No GLP-1-specific enforcement action has been found against Tailor Made Compounding as of March 2026, and the pharmacy’s public quality documentation reflects substantial post-2021 investment in sterile compounding infrastructure.





